Properties
Description
ML 228 is designed to disrupt the hypoxia-inducible factor (HIF) pathway, aiming to hinder cancer cell survival and adaptation in low-oxygen environments characteristic of tumor growth.
Molecular Formula
C27H21N5
Identity
Confirmed by NMR/HPLC/MS.
Applications
ML 228 inhibits HIF, aiding in the study of metabolic pathways and cancer.